|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.07 CNY | +3.53% |
|
+5.25% | -14.04% |
| 10/07 | China Includes Two Mayinglong Pharmaceutical Products in Essential Medicines List | MT |
| 25/05 | Mayinglong Pharmaceutical Gets Regulatory Approval for Eye Drops | MT |
| Market Cap | 10.38B 1.53B 1.34B 1.24B 1.14B 2.16B 146B 2.21B 14.82B 5.81B 71.92B 5.75B 5.62B 248B | P/E 2026 * |
15.4x | P/E 2027 * | 12.8x |
|---|---|---|---|---|---|
| Enterprise Value | 10.38B 1.53B 1.34B 1.24B 1.14B 2.16B 146B 2.21B 14.82B 5.81B 71.92B 5.75B 5.62B 248B | EV / Sales 2026 * |
2.4x | EV / Sales 2027 * | 2.18x |
| Free-Float |
64.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +3.53% | ||
| 1 week | +5.25% | ||
| Current month | +11.33% | ||
| 1 month | +1.01% | ||
| 3 months | -5.46% | ||
| 6 months | -15.28% | ||
| Current year | -14.04% |
| 1 week | 22.61 |  | 24.43 |
| 1 month | 21.22 | | 24.43 |
| Current year | 21.22 | | 29.22 |
| 1 year | 21.22 | | 30.18 |
| 3 years | 20.2 | | 31.46 |
| 5 years | 17.99 | | 33.34 |
| 10 years | 12.52 | | 33.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
You Zhang Xia
CEO | Chief Executive Officer | 48 | 28/05/2019 |
Tao Mao
DFI | Director of Finance/CFO | 49 | 28/12/2023 |
Ping An Liu
PRN | Corporate Officer/Principal | 40 | 19/08/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Ping Chen
CHM | Chairman | 64 | 16/03/2010 |
You Zhang Xia
BRD | Director/Board Member | 48 | 28/05/2019 |
Yue Zhou
BRD | Director/Board Member | 40 | 14/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.53% | +5.25% | -13.10% | -9.58% | 1.48B | |
| -0.56% | -1.52% | +47.86% | +171.88% | 1,060B | |
| +0.31% | -0.60% | +64.37% | +62.31% | 619B | |
| -0.03% | -2.65% | +29.49% | +85.64% | 438B | |
| -1.75% | -2.91% | +28.78% | +24.35% | 333B | |
| +0.24% | -2.61% | +29.46% | +46.50% | 282B | |
| -1.75% | -10.57% | +18.27% | +22.07% | 267B | |
| +0.67% | +1.03% | -26.81% | -37.96% | 218B | |
| -0.81% | -1.63% | +21.35% | +58.33% | 196B | |
| +1.21% | +1.38% | +17.23% | +71.29% | 161B | |
| Average | +0.01% | -2.44% | +21.69% | +49.48% | 357.54B | |
| Weighted average by Cap. | -0.26% | -3.09% | +35.61% | +83.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.32B 637M 559M 517M 476M 900M 60.95B 918M 6.17B 2.42B 29.93B 2.39B 2.34B 103B | 4.75B 701M 615M 570M 524M 991M 67.11B 1.01B 6.79B 2.66B 32.95B 2.63B 2.58B 114B |
| Net income | 674M 99.4M 87.19M 80.75M 74.3M 141M 9.51B 143M 962M 377M 4.67B 373M 365M 16.14B | 745M 110M 96.37M 89.26M 82.13M 155M 10.52B 158M 1.06B 417M 5.16B 413M 404M 17.83B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | CNY 24.07 | +3.53% | 10,594,540 |
| 10/07/26 | CNY 23.25 | -2.31% | 7,708,440 |
| 09/07/26 | CNY 23.80 | +2.28% | 9,739,200 |
| 08/07/26 | CNY 23.27 | +2.06% | 5,155,200 |
| 07/07/26 | CNY 22.80 | -1.51% | 3,776,101 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600993 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
